Cellebrite DI Cash Flow Reinvestment Rate
Cellebrite DI cash flow reinvestment rate. Cellebrite DI (CLBT) has a Cash Flow Reinvestment Rate of 1.20x as of December 2025, reinvesting $98.66 Million (capex $3.96 Million plus investments $-94.70 Million) from operating cash flow of $82.23 Million. Explore CLBT debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cellebrite DI (2019–2025)
Cash flow reinvestment rate of Cellebrite DI from 2019 to 2025. Historical reinvestment intensity for Cellebrite DI across 7 annual periods. Explore Cellebrite DI capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Cellebrite DI Cash Flow Reinvestment Rate by Year (2019–2025)
Cellebrite DI cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Cellebrite DI. For the full cash flow conversion analysis, see Cellebrite DI (CLBT) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | $120.79 Million | $168.96 Million | $13.22 Million | ▼ -41.0% |
| 2024 | 1.21x | $160.08 Million | $132.17 Million | $10.61 Million | ▲ +73.9% |
| 2023 | 0.70x | $71.06 Million | $102.06 Million | $7.92 Million | ▼ -85.7% |
| 2022 | 4.88x | $100.32 Million | $20.58 Million | $9.09 Million | ▲ +115.8% |
| 2021 | 2.26x | $81.45 Million | $36.05 Million | $8.11 Million | ▲ +616.9% |
| 2020 | 0.32x | $20.96 Million | $66.51 Million | $6.18 Million | ▼ -89.1% |
| 2019 | 2.90x | $46.72 Million | $16.13 Million | $6.21 Million | — |